Will Insmed Incorporated's (INSM) New Drugs be Able to Peak Sales? [Yahoo! Finance]
Insmed, Inc. (INSM)
Last insmed, inc. earnings: 4/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insmed.com
Company Research
Source: Yahoo! Finance
The Fund performed roughly in line with the Benchmark, during a challenging quarter for the larger health care industry. A copy of the letter can be downloaded here . The fund declined 9.58% (Institutional Shares) in the quarter compared to a 9.75% decline for the Russell 3000 Health Care Index (benchmark) and a 2.63% gain for the Russell 3000 Index (the Index). For the full year 2024, the fund appreciated 1.55% compared to 3.48% and 23.81% gains for the indexes. In addition, please check the fund's top five holdings to know its best picks in 2024. In its fourth quarter 2024 investor letter, Baron Health Care Fund emphasized stocks such as Insmed Incorporated (NASDAQ: INSM ). Insmed Incorporated (NASDAQ:INSM) is a biopharmaceutical company that develops therapeutic products for patients with serious and rare diseases. The one-month return of Insmed Incorporated (NASDAQ:INSM) was 3.71%, and its shares gained 188.10% of their value over the last 52 weeks. On February 18, 2025, Insmed
Show less
Read more
Impact Snapshot
Event Time:
INSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed, Inc. news events
Weekly update
A roundup of the hottest topics
INSM
News
- INSM Stock Plummets on Sinus Study Failure, Adds New Pipeline Asset [Yahoo! Finance]Yahoo! Finance
- Mizuho's Jared Holz talks Insmed sinking double digits on sinus drug trial news [CNBC]CNBC
- Insmed (NASDAQ:INSM) had its price target lowered by analysts at TD Cowen from $269.00 to $241.00. They now have a "buy" rating on the stock.MarketBeat
- Insmed's Pipeline Can Deliver Potential Gains Despite Brensocatib Setback, RBC Says [Yahoo! Finance]Yahoo! Finance
- Insmed's ‘win streak' ends as top drug fails study in chronic nasal condition [Yahoo! Finance]Yahoo! Finance
INSM
Earnings
- 10/30/25 - Miss
INSM
Sec Filings
- 12/18/25 - Form 144
- 12/17/25 - Form 8-K
- 12/9/25 - Form 4
- INSM's page on the SEC website